Sign in

South Australian immunoGENomics Cancer Institute

@saigenci.bsky.social
57 followers 20 following 27 posts

SAiGENCI is South Australia's world-class cancer research institute, jointly resourced by the Commonwealth Department of Health and Aged Care, Central Adelaide Local Health Network (CALHN) and Adelaide University. Official Adelaide University account.

PostsRepliesMedia
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 04/08/2026
Congratulations to @saigenci.bsky.social's Dr Luke Isbel on being named a 2026 South Australian Young Tall Poppy! A well-deserved recognition of his outstanding research in molecular epigenetics and commitment to science communication and community engagement. bit.ly/3TrrnHQ @aipscience.bsky.social
010
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 04/08/2026
🎉 Congratulations to @saigenci.bsky.social researchers Dr Yannan Yang, Dr Thanh Loc Nguyen and Dr Min Zhang on being awarded #NHMRC Investigator Grants for 2026. Advancing breakthroughs in cancer and neurodegenerative disease research. 👏 🔗 adelaide.edu.au/about/news/2...
adelaide.edu.au
$26.3 Million NHMRC Grant success powers high impact health research at Adelaide University
000
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 29/07/2026
🎉On Monday, Team @saigenci.bsky.social hosted our 2026 The Longest Table morning tea in support of The Hospital Research Foundation Group. Proud to have raised $1,400 for cancer research and patient care at our fifth event. Thanks to everyone who baked, donated, and joined us! 🫖🍵🍰❤️ #forkcancer
000
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 28/07/2026
📣Congratulations to @saigenci.bsky.social's Professor Lisa Butler and team on securing a Tour de Cure Australia Research Grant to support research aimed at improving outcomes for men with prostate cancer. 🔬🧪👏
000
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 15/07/2026
📢 New opportunity @acepigenetics.bsky.social and @saigenci.bsky.social! Looking for a Group Leader in Epigenetics to join a leading interdisciplinary research centre and lead a globally competitive research program in epigenomics. Join us and make your mark! jobs.adelaide.edu.au/cw/en/job/49...
jobs.adelaide.edu.au
Group Leader Epigenetics - Adelaide CBD, SA, Australia
Based in the College of Health, Adelaide Health and Medical Sciences (AHMS) Building Salary per annum: Level B ($117,100-$138,515), Level C ($142,789-$164,207) plus 17% Superannuation 1 Grant Funded R...
000
Reposted by South Australian immunoGENomics Cancer Institute
Stefano Mangiola @stemang.bsky.social · 07/07/2026
Join us! With a fully funded PhD scholarship. www.linkedin.com/feed/update/... @saigenci.bsky.social
linkedin.com
📢 Fully funded PhD position in AI foundation models for cancer immunology Our lab https://lnkd.in/gmgsXEZt This project will develop and apply artificial intelligence models, including foundation… |...
📢 Fully funded PhD position in AI foundation models for cancer immunology Our lab https://lnkd.in/gmgsXEZt This project will develop and apply artificial intelligence models, including foundation mo...
133
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 12/06/2026
📣Congratulations to @saigenci.bsky.social's Dr Mara Zeissig taking out the CMAX Discovery Award at last night's 40 Under 40 award ceremony. Mara is Group Leader of the T cell Immunotherapy Laboratory in the Tumour Inflammation and Immunotherapy program. 👏 www.indailysa.com.au/news/events/...
000
Reposted by South Australian immunoGENomics Cancer Institute
Stefano Mangiola @stemang.bsky.social · 09/06/2026
📢 📃 Finetuning masking challenges narrow-task evaluation of cell foundation models shorturl.at/dcz3l We tested foundation model architectures across extreme reductions in pretraining scale. We found that standard narrow tasks were insensitive to pretraining scale, up tp 128-fold reduction!
biorxiv.org
Finetuning masking challenges narrow-task evaluation of cell foundation models
Single-cell foundation models are large, self-supervised deep learning networks pretrained on millions of cellular transcriptomes. These models promise to deliver cell representations that are transfe...
141
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 14/05/2026
📣Last night we hosted the 2026 @saigenci.bsky.social Annual Public Lecture "Why cancer comes back and how can we stop it?" featuring Program Leads, Lisa Butler and Lan Nguyen. Thanks to our speakers and MC Michael Roy. 👏 Watch the lecture at www.youtube.com/live/QQT61Lj...
000
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 29/04/2026
📰@saigenci.bsky.social 's own Dr Zeyad Nassar featured in @thetiser.bsky.social article on SA researchers developing life-changing cancer breakthroughs. A 2026 Cancer Council SA Research Fellowship recipient for his work in prostate cancer research. Read the full article here bit.ly/4n19IRV 👏
000
Reposted by South Australian immunoGENomics Cancer Institute
Stefano Mangiola @stemang.bsky.social · 24/04/2026
This work started as an internal resource and has now become public with helpful APIs. It was 3+ years in the making, with a massive Thanks to Mengyuan Shen and the whole Team! We hope you find it useful 🙏 @saigenci.bsky.social @wehi-research.bsky.social @bioconductor.bsky.social
021
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 08/04/2026
📣 Great to see this fabulous group attending the first event for 2026 organised by the @saigenci.bsky.social EMCR Committee and welcoming postdocs, students and RAs. A great opportunity to network and share ideas on supporting our community! ☕👏 @acepigenetics.bsky.social
000
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 02/03/2026
📣Read about @saigenci.bsky.social Director, @chrissweens1.bsky.social, discussing advancements in treatment options for prostate cancer at @ascocancer.bsky.social GU Cancers Symposium 2026 in @pharmacytimes.bsky.social at www.pharmacytimes.com/view/a-new-t...
pharmacytimes.com
A New Therapeutic Era in Metastatic Castration-Resistant Prostate Cancer | Pharmacy Times
At 2026 ASCO GU, emerging targets are reshaping how mCRPC is treated.
010
Reposted by South Australian immunoGENomics Cancer Institute
Lorne Genome Conference, Australia @lornegenome.bsky.social · 16/02/2026
Spatial transcriptomics methods can struggle to scale on large datasets, or miss biological structure. Nora Liu @saigenci.bsky.social introduces DOMINO, a diffusion optimised contrastive learning framework for spatial domain detection, an accurate and scalable ST method.
141
Reposted by South Australian immunoGENomics Cancer Institute
Cancer and Immune Signalling Lab (CISL) @jenkins-lab.bsky.social · 10/02/2026
Very pleased to share our latest published work on the role of the innate immune inflammasome adaptor ASC in promoting pancreatic cancer. Thanks to all in our multinational team! pubmed.ncbi.nlm.nih.gov/41654528/ @saigenci.bsky.social @natcomms.nature.com
share.google
Cancer cell-intrinsic inflammasome protein ASC links innate immunity with mitochondrial metabolism in driving pancreatic cancer - PubMed
Pancreatic ductal adenocarcinoma (PDAC) is driven by genetic alterations in the pancreatic epithelium (e.g., KRAS) coupled with dysregulated innate immunity that triggers tumor-promoting chronic inflammation. However, the identity of innate immune molecular regulators as therapeutic targets in PDAC …
011
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 06/02/2026
@saigenci.bsky.social is pleased to be part of the team, led by @petermaccc.bsky.social, awarded $5m from PCFA. @katmorel.bsky.social will bring her expertise to the project team, an extension of "The Daisy Project" led by @chrissweens1.bsky.social See more bit.ly/45PoNyy bit.ly/4alvFW1
021
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 03/02/2026
📣Welcome to our Ainsworth Fellows in the TII program @saigenci.bsky.social, researching the role of inflammation in lung and upper gastrointestinal cancers. Grateful for the generous support of the Ainsworth Foundation. Drs Tamsin Lannagan, Eun-Jung In, Georgette Radford, Rhynelle Dmello. 🧪🔬👏
020
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 12/01/2026
As part of the transition to Adelaide University, this page now represents @saigenci.bsky.social at Adelaide University. Thank you for following and supporting us on our journey under the University of Adelaide. Follow @AdelaideUni for university-wide updates and to explore what’s ahead.
000
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 11/12/2025
📣 The University of Adelaide and @saigenci.bsky.social were proud sponsors of the Australian Ubiquitin Summit 2025, held 16-20 November in Lorne, Victoria bringing together leading scientists, clinicians and industry innovators to explore ubiquitin biology and targeted protein degradation (TPD). 🧪🔬👏
020
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 03/12/2025
📣Kicking off @saigenci.bsky.social's 2025/26 summer research program with a morning tea celebrating the arrival of this year's students. An event filled with conversation and connection as students met each other, engaged with supervisors and SAiGENCI summer student alumni.🎉
011
Reposted by South Australian immunoGENomics Cancer Institute
Monika Mohenska @mmohenska.bsky.social · 03/12/2025
Mechanistic modelling with ODEs and Virtual Cell Models with foundational models this morning at #EMBLAPhD with SAiGENCIs Lan and Anthony - looking forward to more #AI 🦾🤖 @emblaustralia.org @saigenci.bsky.social @acepigenetics.bsky.social
032
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 31/10/2025
Congratulations to @saigenci.bsky.social's @aachinger.bsky.social awarded 2025 Sylvia and Charles Viertel Senior Medical Research Fellowship. Dr Achinger-Kawecka leads our 3D Chromatin Organisation Laboratory and receives $1.375m over 5 years to support her work. Read more at bit.ly/3Wva9HH
020
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 29/10/2025
📣 @saigenci.bsky.social congratulate Professor Jose Polo on his election as Fellow of the Australian Academy of Health & Medical Sciences (AAHMS). Jose is Program Lead for Cancer Epigenetics @SAiGENCI and Director @acepigenetics.bsky.social. Many congratulations Jose! aahms.org/news/29-of-a...
aahms.org
29 of Australia’s leading health and medical researchers elected as AAHMS Fellows - AAHMS
The Australian Academy of Health and Medical Sciences (AAHMS) has announced the election of 29 new Fellows for 2025, recognising the nation’s most outstandi ...
042
Reposted by South Australian immunoGENomics Cancer Institute
Australasian Epigenetic Alliance (AEpiA) @aepia.bsky.social · 09/10/2025
Luke is a group leader at @saigenci.bsky.social & @acepigenetics.bsky.social, within the University of Adelaide. He has extensive expertise in epigenetic regulation and a strong commitment to fostering creative, inclusive science. A perspective we can’t wait to share with our community!
111
Reposted by South Australian immunoGENomics Cancer Institute
Australasian Epigenetic Alliance (AEpiA) @aepia.bsky.social · 17/10/2025
🧵 1/ 💗 𝐈𝐭’𝐬 𝐁𝐫𝐞𝐚𝐬𝐭 𝐂𝐚𝐧𝐜𝐞𝐫 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐌𝐨𝐧𝐭𝐡 💗 We’re spotlighting AEpiA member @aachinger.bsky.social (now at @saigenci.bsky.social) and Prof Susan Clark ( @garvaninstitute.bsky.social) for their research on epigenetic therapy in hormone-driven breast cancer. #BreastCancerAwarenessMonth #AEpiA
111
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 03/10/2025
📣Congratulations to Professor Brendan Jenkins, @saigenci.bsky.social's Program Lead for Tumour Inflammation and Immunotherapy, on being awarded the Japanese Cancer Association (JCA) International Award. The first Australian recipient! @jenkins-lab.bsky.social 👏
010
Reposted by South Australian immunoGENomics Cancer Institute
Adelaide Centre for Epigenetics @acepigenetics.bsky.social · 16/09/2025
Thank you to the China International Talent Exchange Foundation for hosting our young ACE researchers! We shared our epigenetic research and cutting-edge technologies, whilst learning all about the pioneering research in Harbin, China. A wonderful exchange for ideas!🧪 @saigenci.bsky.social
211
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 03/09/2025
📣Last night 90+ uni students attended the inaugural "Evening with Cancer Researchers". Hosted by @saigenci.bsky.social with representatives from University of Adelaide, UniSA's CCB and @sahmri.bsky.social. Great to see the enthusiasm of our next gen cancer researchers! @josundstrom.bsky.social 🔬
010
Reposted by South Australian immunoGENomics Cancer Institute
Adelaide Centre for Epigenetics @acepigenetics.bsky.social · 21/08/2025
Welcome new @saigenci.bsky.social PhD students! SAiGENCI student reps Percy Zhang (Polo lab @acepigenetics.bsky.social ) and An Nguen were thrilled to welcome everyone with this warm gathering!
021
Reposted by South Australian immunoGENomics Cancer Institute
Australian BioCommons @ausbiocommons.bsky.social · 12/08/2025
Next in our #AI webinars: Stefano Mangiola @saigenci.bsky.social talks AI models in #SingleCell and if they can uncover biological patterns Anh TN Nguyen @monashuniversity.bsky.social shares how deep learning is accelerating #DrugDiscovery for GPCRs More info www.biocommons.org.au/events/ai-se...
Flyer advertising upcoming webinars. Photos of the speakers are shown on the right.

The words read: Dr Stefano Mangiola (SAiGENCI)
“Improving the interpretability of AI models for cell biology and precision medicine”

Dr Anh TN Nguyen (Monash)
“Bridging pharmacology and AI: Accelerating GPCR drug discovery with deep learning”

26 August 2025
12 - 1 pm AEST
043
Reposted by South Australian immunoGENomics Cancer Institute
EMBL Australia @emblaustralia.org · 12/08/2025
🧬 DNA’s message is only part of the story. Dr @qizhang85.bsky.social @saigenci.bsky.social is decoding epigenetic modifiers - the hidden editors of gene expression - to uncover new cancer treatments. 🔗 More in our Impact Report: bit.ly/3EVhwD8 #DecodingTheUniverse #ScienceWeek
022
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 13/08/2025
@saigenci.bsky.social are hiring! Work with our fabulous Group Leader, Dr Luke Isbel and the Molecular Epigenetics Laboratory. Luke is seeking a highly motivated, creative researcher to join his team. See all the details at careers.adelaide.edu.au/cw/en/job/51... @acepigenetics.bsky.social
careers.adelaide.edu.au
Learn more about South Australia's new university for the future.
021
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 11/08/2025
📣On Friday, @saigenci.bsky.social hosted a delegation from the Chinese biomedical industry as part of the SJTU-AU Innovation Connect 2025 Australia Biomedical Inspection. Thanks to Lan Nguyen, Michael Roy, Fuji Li and Jing Xu representing @saigenci.bsky.social 👏
010
Reposted by South Australian immunoGENomics Cancer Institute
Stefano Mangiola @stemang.bsky.social · 06/08/2025
Join #AI and #Immunology! 📢 Fully funded #PhD @saigenci.bsky.social: develop AI to chart immune diversity across the population, in #cancer. CV, transcript, and a one-page statement by 30 August 2025 → www.linkedin.com/feed/update/... #PhDOpportunity #MachineLearning #SingleCell
022
Reposted by South Australian immunoGENomics Cancer Institute
Adelaide Centre for Epigenetics @acepigenetics.bsky.social · 28/07/2025
Huge congrats to the ACE team led by Prof Polo, Dr Sullivan, Dr Bhattacharjee, as well as Prof Lister & Dr Pope on their MRFF Grant, tackling the challenge of helping patients with rare neural diseases! @saigenci.bsky.social @ryanlister.bsky.social @perkinsinstitute.bsky.social tinyurl.com/5t4e9x6n
tinyurl.com
Stem cell funding to benefit epigenetic study
011
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 29/07/2025
@saigenci.bsky.social are excited to welcome two new researchers through a fellowship program funded by the Ainsworth Foundation. Dr Georgette Radford and Dr Tamsin Lannagan join the Tumour Inflammation and Immunotherapy program. Read more at www.adelaide.edu.au/newsroom/new... 🔬🧪👏
adelaide.edu.au
Fellows advance immunotherapy and tumour inflammation research
020
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 28/07/2025
Great work Team @saigenci.bsky.social raising over $900 for cancer research at today's The Longest Table morning tea. Donations are still rolling in at www.thelongesttable.com.au/fundraisers/... Supporting THRFG. Together let's #forkcancer! 👊
051
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 10/07/2025
📣 @saigenci.bsky.social thrilled to congratulate Professor Lan Nguyen awarded funding through the ARC's 2025 Future Fellowships scheme for his project "Deciphering contextual multi-pathway crosstalk in cellular decision making". @saigenci.bsky.social's first Future Fellow! bit.ly/4lobxqv 💻🔬👏
arc.gov.au
020
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 19/06/2025
👏Congratulations to Dr Mohamed Saad on your @curecancer.bsky.social Researcher of the Year 2025 award. Proud to have you continuing your important work @saigenci.bsky.social! 🧪🔬👊 www.curecancer.com.au/blog/celebra...
curecancer.com.au
Celebrating brilliance and generosity: Our Cure Cancer 2025 Researcher of the Year Reception
120
Reposted by South Australian immunoGENomics Cancer Institute
EMBL Australia @emblaustralia.org · 01/05/2025
📅 SAVE THE DATE - Our much-loved #PhD Course is turning 10! 🧬 This year, our unique, two-week course will be held at SAiGENCI & focus on #AI in #biology. 👉 For more info, to have your say on course content or to sponsor the event, visit our website: bit.ly/3GNpEpF
011
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 02/06/2025
Updated results from Australian-led ENZAMET trial highlighting long-term outcomes with XTANDI® in mHSPC to be presented at #ASCO25. @saigenci.bsky.social Director @chrissweens1.bsky.social key leader in the ENZAMET study. Check out the full story at oncologynews.com.au/latest-news/...
oncologynews.com.au
ASCO 2025: ARCHES and Australian-led ENZAMET prostate cancer trials to present XTANDI® (enzalutamide) data
000
South Australian immunoGENomics Cancer Institute @saigenci.bsky.social · 23/05/2025
📣 @saigenci.bsky.social are now on @bsky.app! Follow us for the latest news on our exciting research!
010